A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Familial isolated hyperCKaemia is characterized by elevated serum creatine kinase (CK) levels without muscle weakness.
• Mutations in the Caveolin-3 (CAV-3) gene have been implicated in some cases of hyperCKaemia.

Purpose of the Study:

• To investigate the genetic basis of persistent hyperCKaemia in a family without muscle weakness.
• To identify novel mutations in the CAV-3 gene associated with this condition.

Main Methods:

• Serum creatine kinase (CK) levels were measured.
• Muscle biopsy was performed to assess caveolin-3 levels at the sarcolemma.
• Western blot analysis was used to confirm caveolin-3 reduction.
• Mutational analysis of the CAV-3 gene was conducted.

Main Results:

• Three family members presented with persistently elevated serum CK levels and no muscle weakness.
• Muscle biopsy revealed a partial reduction of caveolin-3 at the sarcolemma of muscle fibers.
• A novel heterozygous mutation (G-->A transition at nucleotide 169 in exon 2 of the CAV-3 gene) was identified, resulting in a Val-->Met change at codon 57.
• This is the second identified mutation in the CAV-3 gene linked to familial isolated hyperCKaemia.

Conclusions:

• A novel heterozygous mutation in the CAV-3 gene is associated with familial isolated hyperCKaemia.
• Caveolin-3 deficiency plays a role in the pathogenesis of this condition.
• Further research into CAV-3 mutations is warranted for understanding hyperCKaemia.